ENSY news

Latest 1 stories · newest Nov 4, 2026

ENSY

Ensysce Biosciences amended Dr. Lynn Kirkpatrick's employment and title to Chief Operating Officer effective January 1, 2027. Market relevance is null as no financial guidance was issued.

Leadership Nov 4, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ENSY feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ENSY/newsSTART FREE